INDUSTRY NOTES: OIG To Oncologists--Tighten Your Belts
Plus: Don't let a CMS edit keep you from appealing radiology claimsCancer practices are doing fine, insists the HHS Office of Inspector General in the latest of a long line of reports on oncology drugs. The OIG surveyed a dozen oncology practices and found that nine of them could buy 15 cancer drugs at the Medicare rate or cheaper. The other three practices, however, had to pay more than the Medicare rate for at least half of those drugs. Unfortunately, 11 out of 12 practices didn't have any way to track the costs of providing the drugs, apart from...
To read the full article, sign in and subscribe to tci Medicare Compliance & Reimbursement.
Keep pace with evolving Medicare regulations — and onboard your team — with timely analysis of critical updates interpreted in an easy-to-follow, easy-to-apply format. Your subscription to TCI's Medicare Compliance & Reimbursement Alert will equip you to navigate code and guideline changes, CCI edits, and revisions to modifiers, payer policies, the fee schedule, OIG target areas, and more.
Current newsletters added each month
Fully searchable archives - over 4200 articles
ALL years/issues back to 2003 organized by year and issue
Codes mentioned in articles are linked to Code Information pages
Code Information pages link back to related articles
Access to this feature is available in the following products: